Island Pharmaceuticals Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Key Metrics
PE ratio
-
PB ratio
14.00
Dividend yield
-
Beta
0.16
Market cap
$113.00M
Enterprise value
$96.59M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.islandpharmaceuticals.com |
| Mailing address | 117 Camberwell Road Suite 1.01 Hawthorn East VIC 3123 Australia |
| Phone / Fax | 61 3 7036 7675 / |
Dividends
More: Island Pharmaceuticals Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Island Pharmaceuticals paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ILA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Island Pharmaceuticals.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. David Charles Foster J.D., M.A.I.C.D., Ph.D. | MD, CEO, President & Executive Director | ||
| Mr. Cameron Peter Jones C.A. | CFO & Company Secretary |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-11092.54%
Return on assets
-49.16%
Return on equity
-90.37%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Island Pharmaceuticals is 113.00M and its enterprise value is 96.59M. The enterprise value to revenue ratio of ILA is 812.27. The enterprise value to EBITDA ratio of ILA is -.
The ILA's stocks Beta value is 0.16 making it 84% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Island Pharmaceuticals (ILA)
Island Pharmaceuticals (ASX:ILA) Frequently Asked Questions
1. What is Island Pharmaceuticals's Stock Symbol?
Island Pharmaceuticals trades on ASX under the ticker symbol "ILA".
2. What is Island Pharmaceuticals's stock price today?
One share of ILA stock can currently be purchased for approximately $0.42.
3. How can I contact Island Pharmaceuticals?
Island Pharmaceuticals's mailing address is 117 Camberwell Road Suite 1.01 Hawthorn East VIC 3123 Australia. The company can be reached via phone at 61 3 7036 7675.
4. What is Island Pharmaceuticals's official website?
The official website of Island Pharmaceuticals is https://www.islandpharmaceuticals.com.